Colinz Laboratories Ltd

BOM:531210 (India)  
₹ 42.47 (+2.58%) Jun 7
29.49
P/B:
1.20
Market Cap:
₹ 106.99M ($ 1.28M)
Enterprise V:
₹ 42.68M ($ 511.00K)
Volume:
836.00
Avg Vol (2M):
3.44K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Colinz Laboratories Ltd ( BOM:531210 ) from 1995 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Colinz Laboratories stock (BOM:531210) PE ratio as of Jun 10 2024 is 29.49. More Details

Colinz Laboratories Ltd (BOM:531210) PE Ratio (TTM) Chart

To

Colinz Laboratories Ltd (BOM:531210) PE Ratio (TTM) Historical Data

Total 1255
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Colinz Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 29.5 2024-04-01 27.0
2024-06-07 29.5 2024-03-28 26.1
2024-06-06 28.8 2024-03-27 27.1
2024-06-05 28.6 2024-03-26 27.2
2024-06-04 27.6 2024-03-22 27.5
2024-06-03 27.2 2024-03-21 27.9
2024-05-31 27.4 2024-03-20 27.6
2024-05-29 28.7 2024-03-19 27.7
2024-05-28 28.6 2024-03-18 26.9
2024-05-27 29.9 2024-03-14 28.4
2024-05-24 29.5 2024-03-13 28.1
2024-05-23 28.9 2024-03-12 28.6
2024-05-22 28.6 2024-03-11 29.0
2024-05-21 31.1 2024-03-07 28.5
2024-05-17 29.6 2024-03-06 29.3
2024-05-16 30.6 2024-03-05 28.4
2024-05-15 28.8 2024-03-04 29.3
2024-05-14 28.9 2024-03-01 28.9
2024-05-13 28.9 2024-02-29 29.7
2024-05-10 29.3 2024-02-28 28.9
2024-05-09 29.9 2024-02-27 27.6
2024-05-08 31.5 2024-02-26 28.0
2024-05-07 29.9 2024-02-23 28.5
2024-05-06 32.2 2024-02-22 29.5
2024-05-03 31.9 2024-02-21 29.6
2024-05-02 29.2 2024-02-20 28.8
2024-04-30 28.8 2024-02-19 29.2
2024-04-29 27.4 2024-02-16 29.0
2024-04-26 28.6 2024-02-15 29.4
2024-04-25 28.6 2024-02-14 29.2
2024-04-24 29.9 2024-02-13 28.6
2024-04-23 28.0 2024-02-12 28.3
2024-04-22 29.4 2024-02-09 29.2
2024-04-19 27.1 2024-02-08 29.1
2024-04-18 27.6 2024-02-07 29.2
2024-04-16 27.8 2024-02-06 28.2
2024-04-15 28.4 2024-02-05 29.1
2024-04-12 30.1 2024-02-02 29.0
2024-04-10 28.2 2024-02-01 28.3
2024-04-09 28.3 2024-01-31 27.5
2024-04-08 27.5 2024-01-30 27.5
2024-04-05 29.4 2024-01-29 27.1
2024-04-04 27.9 2024-01-25 27.8
2024-04-03 27.9 2024-01-24 27.8
2024-04-02 28.2 2024-01-23 27.4

Colinz Laboratories Ltd (BOM:531210) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.